The Rockies placed right-hander Ryan Feltner on the 15-day injured list on Friday, and called up left-hander Sammy Peralta from Triple-A in the corresponding move.  Feltner is dealing with right ulnar nerve inflammation, which forced him out of his start on Thursday (a 10-8 Rockies loss to the Padres) after two innings of work.

Manager Warren Schaeffer described the issue as “just a little elbow inflammation” when speaking with MLB.com’s Bill Ladson and other reporters.  Since Feltner’s “MRI looked pretty good,” the Rox are hopeful that the righty will be back after just a minimal 15-day absence.

Feltner allowed two runs in his abbreviated outing against San Diego, boosting his ERA to 6.30 over five starts and 20 innings this season.  His 4.46 SIERA is almost two runs lower than his ERA and Thursday’s start could be considered a wash due to his injury, yet Feltner’s Statcast metrics are uniformly below average at this early point in the season.  In particular, opposing batters have been laying into Feltner’s pitches to the tune of a 49.2% hard-hit ball rate and a 15.9% barrel rate.

As Ladson observed, injuries have been a persistent issue for Feltner during his career, including a 2025 season that saw the righty limited to 30 1/3 innings due to back spasms and a shoulder problem.  The most frightening of Feltner’s injuries was a skull fracture and a concussion sustained after he was hit in the head by a Nick Castellanos line drive in May 2023, which resulted in another shortened season of only 43 1/3 frames.

The Rockies’ scheduled game with the Mets today has been rained out, and the two teams will play a doubleheader on Sunday.  With the pitching schedule already a little scrambled, the Rox will likely get through the doubleheader and then Monday’s offday before addressing Feltner’s rotation spot.  Kyle Freeland has been on the 15-day IL since April 13 due to some minor shoulder inflammation and could be back when first eligible, as Freeland tossed 41 pitches over a two-inning simulated outing on Wednesday.

View Comments (0)